{"id":516499,"date":"2010-04-05T17:00:14","date_gmt":"2010-04-05T21:00:14","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=71816"},"modified":"2010-04-05T17:00:14","modified_gmt":"2010-04-05T21:00:14","slug":"another-8m-for-dyax-in-stock-deal","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/516499","title":{"rendered":"Another $8M for Dyax in Stock Deal"},"content":{"rendered":"\n
Biotech<\/a>, funding<\/a>, deals<\/a><\/div>\n

\t\tErin Kutz wrote:<\/strong><\/p>\n

Dyax<\/a> (NASDAQ: DYAX<\/a>), a Cambridge, MA-based developer of a drug for an inflammatory disease, has raised $59.6 million in a stock deal. Last month the company raised $51.8 million through the sale of 17 million shares at $3.25 per share<\/a>, and raised an additional $8 million when underwriter Jefferies & Company exercised its over-allotment option to purchase an additional 2.55 million shares of common stock at $3.25 per share, in a sale<\/a> that closed today. The funding from the stock offering will go to Dyax’s Kalbitor (ecallantide), a drug for treating acute attacks of an inflammatory disease called hereditary angioedema.<\/p>\n

Comments<\/a> | Reprints<\/a> | Share:  
\n\"Retweet\"\/<\/a>
\n \"Facebook\"\/<\/a>
\n \"Email\"\/<\/a>
\n \"Share\"\/<\/a>\n<\/div>\n

UNDERWRITERS AND PARTNERS
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t<\/a>
\n\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t<\/a>
\n\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t<\/a>
\n\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t<\/a>
\n\t\t\t\t\t\t<\/p>\n

\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t<\/a>
\n\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t<\/a>
\n\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t<\/a>
\n\t\t\t\t\t\t\t\t\t

\n

\n\"\"<\/a>
\n<\/p>\n

<\/img><\/a>
\n<\/img><\/a><\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Biotech, funding, deals Erin Kutz wrote: Dyax (NASDAQ: DYAX), a Cambridge, MA-based developer of a drug for an inflammatory disease, has raised $59.6 million in a stock deal. Last month the company raised $51.8 million through the sale of 17 million shares at $3.25 per share, and raised an additional $8 million when underwriter Jefferies […]<\/p>\n","protected":false},"author":1661,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-516499","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/516499","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1661"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=516499"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/516499\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=516499"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=516499"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=516499"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}